Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01810016
What this trial is testing

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Ludwig Institute for Cancer Research 8
Very early researchLooking for participantsNCT06496373
What this trial is testing

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectableChemotherapy-intolerant
Ruijin Hospital 20
Early research (Phase 1)Ended earlyNCT03422094
What this trial is testing

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 3
Very early researchStudy completedNCT03449459
What this trial is testing

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Shanghai Zhongshan Hospital 144
Not applicableStudy completedNCT02151773
What this trial is testing

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

Who this might be right for
Measles/Rubella
Takeda 3,493
Early research (Phase 1)Study completedNCT00000946
What this trial is testing

Test the Safety of Three Experimental HIV Vaccines

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00727441
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Testing effectiveness (Phase 2)Study completedNCT02938442
What this trial is testing

Vaccination of Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast CancerBreast Neoplasms
University of Arkansas 16
Early research (Phase 1)Study completedNCT02238756
What this trial is testing

Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults

Who this might be right for
Rabies
CureVac 72
Testing effectiveness (Phase 2)UnknownNCT05162482
What this trial is testing

Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)

Who this might be right for
COVID 19 Vaccine
Aga Khan University Hospital, Pakistan 1,680
Large-scale testing (Phase 3)UnknownNCT04656613
What this trial is testing

A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE

Who this might be right for
Covid19SARS-CoV Infection
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 1,000
Early research (Phase 1)Looking for participantsNCT07565740
What this trial is testing

Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC

Who this might be right for
HPV-positive Oropharyngeal Squamous Cell Carcinoma
West China Hospital 9
Early research (Phase 1)Ended earlyNCT02460367
What this trial is testing

Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerProgression of Non-small Cell Lung CancerNon-small Cell Lung Cancer Recurrent
NewLink Genetics Corporation 16
Early research (Phase 1)Study completedNCT01435499
What this trial is testing

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Not applicableStudy completedNCT01813487
What this trial is testing

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E

Who this might be right for
Chronic Hepatitis B
Genexine, Inc. 6
Early research (Phase 1)Study completedNCT00471471
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Intraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin)
Ahmad Tarhini 22
Early research (Phase 1)Not Yet RecruitingNCT07686744
What this trial is testing

Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaAdvancedRecurrent+1 more
Jian Lin 8
Large-scale testing (Phase 3)Active Not RecruitingNCT05091619
What this trial is testing

BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed

Who this might be right for
Whooping CoughDiphtheriaTetanus
China National Biotec Group Company Limited 2,898
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Testing effectiveness (Phase 2)Study completedNCT00300950
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer

Who this might be right for
Pancreas Cancer
GlobeImmune 176
Next Page